Deep sea fishermen chase marlins and bluefin tuna. Big dermatology companies chase market share in aesthetics (think Botox), psoriasis and acne, even though effective treatments are rare in the latter two indications. The dermatology company Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) decided to fish in a lake with its drug-device combination treatment VP-102.